Scientists say a new study into weight loss drugs like Mounjaro, Wegovy and Ozempiccan suggest the impact of GLP-1 medicines "may reach further and transform how we think about cancer prevention"

The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.

Experts from the US examined data on more than 161,000 patients